Pulsetto vs Truvaga: Two Cervical Vagus Nerve Devices Compared
Truvaga is a handheld cervical vagus nerve stimulation device from electroCore, designed for on-demand calm in two-minute applications. Here's how it compares with Pulsetto on mechanism, session length, evidence, and value.
- Both target the cervical vagus nerve non-invasively, but Pulsetto stimulates both sides of the neck at once and is hands-free, while Truvaga is a handheld unit you press against one side at a time.
- Pulsetto runs 4-minute guided sessions across multiple modes (stress, sleep, anxiety, burnout, focus); Truvaga uses a 2-minute on-demand protocol.
- Both are general wellness devices, not FDA-cleared treatments. Truvaga's sibling product gammaCore is the FDA-cleared prescription option for migraine and cluster headache.
- Pulsetto is the lower-cost option at around $251 versus Truvaga at $499; neither charges a subscription for core use.
- Pulsetto reports its own randomized open-label pilot (n=40); Truvaga benefits from electroCore's longer track record in cervical nVNS through the gammaCore lineage.
Product Overview
Pulsetto
- MechanismDirect tVNS (neck)
- Session4 minutes
- Clinical RCTYes — INLITA 2025
- Modes5 targeted modes
- Money-back30 days (used)
Truvaga
- MechanismHandheld cervical (neck) nVNS, applied by hand to one side at a time
- Session2-minute sessions, held manually against the neck
- Clinical RCTDraws on electroCore's broader nVNS research heritage
- ModesSingle guided stimulation protocol with intensity control via free app
- Money-backGeneral wellness (sibling gammaCore is FDA-cleared Rx)
We scored both devices across the dimensions that matter most for everyday vagus nerve use: clinical evidence, session length, ease of use, value, and app experience. Scores reflect publicly available specs, each brand's own published data, and the independent tcVNS research base; they are editorial judgments for general wellness use, not medical ratings.
Full Feature Comparison
| Category | Pulsetto ★ | Truvaga |
|---|---|---|
| Technology | ||
| Mechanism | Direct tVNS | Handheld cervical nVNS applied by hand |
| Vagus nerve targeted? | ✓ Directly | Yes - cervical (neck) branch |
| Stimulation site | Neck (vagus nerve) | One side of the neck at a time, held manually |
| Clinical Evidence | ||
| Independent RCT | Yes — UAB INLITA | Brand-cited data plus electroCore's nVNS heritage |
| Objective biomarker | ✓ Cortisol (hair) | Cervical tcVNS biomarkers documented in literature |
| Anxiety reduction | 45% (GAD-7) | General wellness relaxation claims |
| Sleep improvement | 41% (PSQI) | General wellness relaxation claims |
| Usability | ||
| Daily session | 4 minutes | 2-minute on-demand applications |
| All-day wearable | ✕ | No - handheld, used in short sessions |
| Price & Policy | ||
| Starting price | From $290 | $499 |
| Trial policy | 30-day money-back (used) | General wellness; gammaCore sibling is FDA-cleared Rx |
Head-to-head Rounds
Round 1Pulsetto wins
Both devices stimulate the cervical vagus nerve in the neck without needles or implants, the key shared mechanism. The difference is how stimulation is delivered.
Direct tVNS — same mechanism as implanted VNS therapy.
Truvaga is a handheld unit you hold against one side of your neck for each two-minute application, controlling intensity through its free app. It delivers cervical nVNS effectively but requires you to position and hold it manually, one side at a time. Pulsetto, by contrast, is a hands-free collar that stimulates both sides of the neck simultaneously, leaving you free to sit back during a session - an edge in convenience and bilateral coverage.
Round 2Truvaga leads
Neither device is FDA-cleared, and both lean on the broader transcutaneous cervical VNS research base rather than large published trials of the consumer product itself.
Direct tVNS — same mechanism as implanted VNS therapy.
Truvaga benefits from electroCore's longer heritage in cervical nVNS: its sibling device gammaCore is FDA-cleared as a prescription treatment for migraine and cluster headache, which lends the cervical-stimulation approach a deeper research pedigree. Truvaga itself is sold as general wellness and cites that lineage rather than its own large trials. Pulsetto reports a randomized open-label pilot (n=40) it funded, which is not peer-reviewed. On evidence depth the two are comparable, with Truvaga's family pedigree giving it a slight edge.
Round 3Pulsetto wins
Usability covers setup, session flow, and how easily the device fits into a daily routine.
Direct tVNS — same mechanism as implanted VNS therapy.
Truvaga is straightforward: open the app, set intensity, and hold the unit to your neck for two minutes. It is portable and quick, but it occupies a hand throughout and only treats one side per application. Pulsetto's hands-free, bilateral collar is easier to integrate into longer relaxation, work breaks, or pre-sleep wind-down since you don't have to hold anything.
Round 4Pulsetto wins
Price reflects the upfront cost and any ongoing fees for normal use.
Direct tVNS — same mechanism as implanted VNS therapy.
Truvaga is a one-time purchase at $499 with a free app and no subscription, which is fair for a no-recurring-cost device but sits at the higher end of the consumer VNS range. Pulsetto covers the same cervical-VNS use case at roughly $251 with no subscription for core functionality, making it the stronger value for most buyers.
Who Should Choose Each Device?
Choose Pulsetto if…
- You want a hands-free device that stimulates both sides of the neck at once, so you can relax without holding anything
- You prefer guided 4-minute sessions with distinct modes for stress, sleep, anxiety, burnout, and focus
- You want the lower upfront price (around $251) for an at-home cervical VNS routine
- You like having a structured app program rather than a single on-demand protocol
Choose Truvaga if…
- You prefer a simple handheld unit you press to your neck for quick two-minute resets
- You value electroCore's longer pedigree in cervical nVNS and its FDA-cleared sibling gammaCore
- You want a no-subscription device and don't mind the higher $499 price
- You like a single, repeatable on-demand protocol over a multi-mode program
Our recommendation: The Verdict: Same Lane, Different Fit
Pulsetto and Truvaga are unusually close: both are non-invasive cervical vagus nerve stimulation devices marketed for everyday relaxation, and both are general wellness products rather than FDA-cleared treatments. The practical differences decide it. Choose Pulsetto if you want hands-free, bilateral stimulation, guided 4-minute sessions across multiple modes, and a lower price point around $251 for a daily stress and sleep routine. Choose Truvaga if you prefer a handheld two-minute reset and value electroCore's longer cervical nVNS track record, including its FDA-cleared sibling gammaCore for diagnosed conditions. For most people building an at-home, hands-free calm habit, Pulsetto offers more session structure and better value; Truvaga suits those who want a simple handheld tool from an established neuromodulation maker.
Get Pulsetto →Frequently Asked Questions
No. Pulsetto is a general wellness device, certified CE and FCC, and is not FDA-cleared or approved. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any condition. If you specifically want an FDA-cleared cervical VNS product, Truvaga's sibling device gammaCore is the FDA-cleared prescription option (for migraine and cluster headache); Truvaga itself is also a general wellness device.
Do not use Pulsetto if you have a pacemaker or other implantable electronic medical device, a history of epilepsy or seizures, or if you are pregnant. If you have any underlying medical condition or are unsure, consult a healthcare professional before use. The same general cautions apply to other neurostimulation devices, including Truvaga.
Both are non-invasive cervical vagus nerve stimulation devices, but Pulsetto is a hands-free collar that stimulates both sides of the neck at once in 4-minute guided sessions across several modes, while Truvaga is a handheld unit you press to one side of the neck for two-minute applications. Pulsetto is also lower-priced (around $251 vs $499).
No. Both devices offer their core functionality without a mandatory subscription. Truvaga is a one-time $499 purchase with a free app, and Pulsetto's core sessions are available without a recurring fee after the roughly $251 purchase.
No, but they share a maker. Truvaga and gammaCore are both made by electroCore and use cervical nVNS. gammaCore is an FDA-cleared prescription medical device for migraine and cluster headache, while Truvaga is sold as a general wellness device for everyday relaxation. Pulsetto, like Truvaga, is a general wellness device and is not a treatment for any condition.
Sources & References
- [1]Acute transcutaneous cervical but not auricular vagus nerve stimulation increases alpha wave brain activity and lowers arterial blood pressure — Ahmed et al., American Journal of Physiology, 2025
- [2]Quantifying acute physiological biomarkers of transcutaneous cervical vagal nerve stimulation in the context of psychological stress — Gurel et al., Brain Stimulation, 2019
- [3]A systematic review of the effects of transcutaneous auricular vagus nerve stimulation on baroreflex sensitivity and heart rate variability in healthy subjects — Soltani et al., Clinical Autonomic Research, 2023
- [4]Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Insomnia Disorder: A Randomized Clinical Trial — Zhang et al., JAMA Network Open, 2024
- [5]Transcutaneous auricular vagus nerve stimulation inhibits mental stress-induced cortisol release — Cuberos Paredes et al., Physiological Reports, 2025
